Alkem Laboratories Reports Q2 Net Profit Decline Despite Revenue Growth

<b>Alkem Laboratories</b> reported a consolidated net profit of ₹675 crore for the second quarter ended September 30, 2026, marking a decrease of nearly 12 per cent compared to the previous year. However, the company posted total revenue from operations at ₹4,552 crore, reflecting a 13.8 per cent increase over the same period. Managing Director Sandeep Singh stated that biotech sales dropped due to the lumpy nature of the contract development and manufacturing organization business. Meanwhile, domestic sales reached ₹3,027 crore with a 9.5 per cent growth, while international sales grew by 22.3 per cent to stand at ₹1,454 crore.